Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.

Ozempic (semaglutide) is a well-known prescription drug that’s used to treat blood sugar of people with type 2 diabetes, has ...

The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

Amid growing concerns over counterfeit weight loss medications, a local clinical trial may offer a safer alternative for ...

A simple online search for semaglutide, the active ingredient in Ozempic or Wegovy, can lead consumers down a rabbit hole of seemingly reputable online pharmacies in search of weight loss drugs at ...

Novo Nordisk’s net profit of $3.94bn represents a 21% increase from Q3 2023. Net sales in the quarter jumped by the same ...

Novo Nordisk has dominated the obesity space with Wegovy (semaglutide ... from 2018 to 2023, using the company’s Virtual Care ...

A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the weight-loss effects of the two blockbuster slimming jabs ...

Endevica Bio has launched a new spin-off company, Abisati, to accelerate its obesity candidate into clinical trials.